In-silico designing and characterization of binding modes of two novel inhibitors for CB1 receptor against obesity by classical 3D-QSAR approach
Paediatrics and Child Health; Women and Child Health
Obesity is the fifth primary hazard for mortality in the world; hence different therapeutic targets are explored to overcome this problem. Endocannabinoid is identified as the emerging target for the treatment of obesity as Cannabinoid 1 (CB1) receptor over-activation resulted in abdominal obesity. Potent antagonists or inverse agonists for CB1 receptor are the new strategies to develop anti-obesity drugs. Here, ligand-based 3D-QSAR studies was performed on 100 analogues belonging to a class of 1,2,4-tirazole containing diarylpyrazolylcarboxamide as CB1 receptor antagonists. We developed three CoMFA models using different charge schemes, AM1BCC, Gasteiger-Huckle and MMFF. These models produced almost similar statistical results (q2cv = 0.725, 0.692, 0.719 and r2ncv = 0.929, 0.924, 0.928 for AM1BCC, Gasteiger-Huckle and MMFF, respectively). The said models were validated through 20 external test set compounds which resulted in significant r2pred values (r2pred = 0.747, 0.743 and 0.745 for AM1BCC, Gasteiger-Huckle and MMFF, respectively). Comparatively, AM1BCC model provided slightly better statistics among all three tested charges scheme models, hence AM1BCC model was further utilized to generate CoMSIA models considering different field combinations. The best selected CoMSIA model also produced substantial q2cv = 0.788, r2ncv = 0.916 and r2pred = 0.836 values. Furthermore, two new molecules were designed by modifying the same scaffolds on the basis contour map analysis. The activities of newly designed molecules were predicted through obtained CoMFA model ranked as better than their parent molecules. Moreover, these newly designed compounds were successfully docked on the complex crystal structure of CB1 receptor (PDB ID: 5XRA). The docked conformation of these newly designed inhibitor interacted with Ser173, His178, Lys192, Thr197 and Ser383 mainly by hydrophobic and pi-pi stacking interactions. The obtained results signify the potential of the developed model; suggesting that the models can be useful to test and design potent novel CB1 receptor antagonists or inverse agonists prior to the synthesis.
Journal of Molecular Graphics and Modelling
Halim, S. A.,
Zafar, S. K.,
Haq, Z. U.
(2019). In-silico designing and characterization of binding modes of two novel inhibitors for CB1 receptor against obesity by classical 3D-QSAR approach. Journal of Molecular Graphics and Modelling, 89, 199-214.
Available at: https://ecommons.aku.edu/pakistan_fhs_mc_women_childhealth_paediatr/883